Compositions comprising a combination of an anti-LAG-3 antibody, a PD-1 pathway inhibitor, and an immunotherapeutic agent

• 收藏
• 分享

专利权人:

Bristol-Myers Squibb Company

发明人:

Korman, Alan J.,Lonberg, Nils,Selby, Mark J.,Jackson, Jeffrey

申请号：

AU2018277559

公开号：

AU2018277559A1

申请日:

2018.05.30

申请国别(地区):

AU

年份:

2019

代理人:

摘要：

The invention provides a method for treating malignant tumors such as late stage solid tumors in clinic. According to the method, a combination of an LAG-3 antibody, an anti-PD-1 antibody, and an immunotherapy agent is used.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/